AVITA Medical, Inc. (RCEL) Receivables - Net (2018 - 2026)

AVITA Medical (RCEL) has reported Receivables - Net for 9 consecutive years, with $9.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Receivables - Net fell 12.72% year-over-year to $9.9 million; the trailing twelve-month figure through Jun 2026 stood at $9.9 million (down 12.72% YoY), and the FY2025 full-year result was $9.1 million, down 22.88% from the prior year.
• Receivables - Net climbed to $9.9 million in Q2 2026 per RCEL's latest filing, from $9.1 million in the prior quarter.
• Across five years, Receivables - Net topped out at $12.0 million in Q1 2025 and bottomed at $3.5 million in Q1 2022.
• Historically, Receivables - Net has averaged $7.5 million across 5 years, with a median of $7.7 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Receivables - Net soared 118.04% in 2023, then slipped 22.88% in 2025.
• Over 5 years, Receivables - Net stood at $3.5 million in 2022, then surged by 118.04% to $7.7 million in 2023, then surged by 53.97% to $11.8 million in 2024, then slipped by 22.88% to $9.1 million in 2025, then increased by 8.79% to $9.9 million in 2026.
• According to Business Quant data, Receivables - Net over the past three periods registered $9.9 million, $9.1 million, and $9.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.